BSE filing, NSE: TRIMURTHI. Summary written from the filing by ALFA Finder's alert engine.
Novelix Pharmaceuticals Ltd: key numbers
- Share price
- ₹69.49
- Market cap
- ₹122.4 Cr
- Revenue (annual)
- ₹132.3 Cr
- Net profit (annual)
- ₹2.56 Cr
- P/E (TTM)
- 26.3×Sector 65.7×
- Promoter holding
- 54.29%+3.72% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Novelix Pharmaceuticals Ltd
All →Novelix Pharmaceuticals Management Change
Novelix Pharmaceuticals redesignated Venkateshwarlu Pulluru from Whole-Time Director to Non-Executive Director from 11 November 2026. He stays on the Board but gives up executive duties.
Novelix Pharmaceuticals Other Announcement
Novelix Pharmaceuticals reported no deviation in its July 2026 fund raise utilisation for the September quarter. This periodic statement records no new business event.
Novelix Pharmaceuticals Q2 FY27 Results: Net Profit ₹1.6 Cr, Up 220.0% YoY
Novelix Pharmaceuticals Ltd reported revenue from operations of ₹44.7 Cr (+22.8% YoY) and net profit of ₹1.6 Cr (+220.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1.6 Cr · +220.0% YoY
Novelix Pharmaceuticals Board Meeting Date
Novelix Pharmaceuticals has given prior intimation of a board meeting on 11 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. The trading window stays closed until forty-eight hours after the meeting.
Novelix Pharmaceuticals Other Announcement
Novelix Pharmaceuticals Ltd has filed its quarterly shareholding pattern as per SEBI Regulation 31(1)(b) for the period ended September 30, 2026.
Novelix Pharmaceuticals Management Change
Novelix Pharmaceuticals announced the appointment of Mr. Gnana Prakash Gattu as Whole Time Director, approved by shareholders at the company's 32nd Annual General Meeting.
Other business update announcements
All →Amwill Health Care Business Update
Amwill Health Care signed an exclusive private-label supply agreement with a Thai pharma manufacturer. The five-year deal covers hair colour imports for India, with no upfront payment.
- Execution
- 5 years
Kothari Industrial Corporation Business Update
Kothari Industrial intimated plans to relocate its KICKERS showroom from Indore. The destination city, premises and timing remain undecided.
Vishnu Chemicals Business Update
Vishnu Chemicals' Parwada plant in Visakhapatnam resumed full operations on 13 November 2026. The earlier temporary stoppage was for forward integration and new capital projects.
Sharp Chucks And Machines Business Update
SCML entered a PPA with Spark Grid Project B for captive renewable energy, acquiring 26% equity in the SPV. No contract value or capacity is disclosed.
DEE Development Engineers Business Update
DEE Development Engineers reported its October 2026 order book with a closing position of $2,586.43 million. No single new award is announced in this periodic update.
Edelweiss Financial Services Business Update
Edelweiss released a business update of its subsidiary Zuno General Insurance. The deck covers industry outlook, growth dynamics, approach and aspirations, with no monetary figures.